X Zhang, W Xiao, Q Zhang, D Xia, P Gao… - Current …, 2022 - ncbi.nlm.nih.gov
Moyamoya disease (MMD) is a chronic cerebrovascular disease characterized by progressive stenosis of the arteries of the circle of Willis, with the formation of collateral …
EY Zheng, S Hara, M Inaji, Y Tanaka, T Nariai… - Journal of …, 2023 - thejns.org
OBJECTIVE The aim of this study was to evaluate whether indirect revascularization in pediatric patients with moyamoya disease leads to periventricular anastomosis (PVA) …
Intracranial atherosclerotic disease and resultant intracranial stenosis is a global leading cause of stroke, and poses an ongoing treatment challenge. Among patients with …
Y Zhao, J Li, J Lu, Q Zhang, D Zhang, R Wang… - Journal of …, 2019 - thejns.org
OBJECTIVE The effect of indirect revascularization to improve cerebral perfusion for moyamoya disease (MMD) is based on ingrowth of new vessels into the cortical brain …
Rethinking Cerebral Bypass Surgery - Neurosurgery Clinics Skip to Main Content Advertisement Neurosurgery Clinics Log in Register Log in Subscribe Claim Cart (8 items)8 Skip menu …
Moyamoya disease (MMD) is a chronic, progressive cerebrovascular disease involving the occlusion or stenosis of the terminal portion of the internal carotid artery (ICA) and the …
OBJECTIVE The only effective treatment for ischemic moyamoya disease (iMMD) is cerebral revascularization by an extracranial to intracranial bypass. The preferred revascularization …
Y Zhao, S Yu, J Lu, L Yu, J Li, Y Zhang, D Zhang… - Frontiers in …, 2018 - frontiersin.org
Objective: Extracranial-intracranial bypass is currently recognized as the optimal treatment for hemorrhagic-type moyamoya disease (MMD) which reduces incidence of rebleeding …
M Lu, H Zhang, S Liu, D Liu, P Peng, F Hao… - Journal of Neurology …, 2023 - jnnp.bmj.com
Objectives We aimed to compare the long-term outcomes and surgical benefits between moyamoya disease (MMD) and atherosclerosis-associated moyamoya vasculopathy (AS …